2-(CYCLOPENTYLMETHOXY)-5-METHYLANILINE
|
- $205 - $1150
- Product name: 2-(CYCLOPENTYLMETHOXY)-5-METHYLANILINE
- CAS: 946682-80-0
- MF: C13H19NO
- MW: 205.3
- EINECS:
- MDL Number:MFCD08687513
- Synonyms:2-(CYCLOPENTYLMETHOXY)-5-METHYLANILINE;Benzenamine, 2-(cyclopentylmethoxy)-5-methyl-
4 prices
Selected condition：
Brand
- A1 Biochem Labs
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500.00mg
- 500MG
- 2.5g
- ManufacturerA1 Biochem Labs
- Product number6588310
- Product description2-(Cyclopentylmethoxy)-5-methylaniline 95%
- Packaging2.5g
- Price$1150
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0088753
- Product description2-(CYCLOPENTYLMETHOXY)-5-METHYLANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022096
- Product description2-(Cyclopentylmethoxy)-5-methylaniline
- Packaging500.00mg
- Price$205
- Updated2026-05-18
- Buy
- ManufacturerMatrix Scientific
- Product number022096
- Product description2-(Cyclopentylmethoxy)-5-methylaniline
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| A1 Biochem Labs | 6588310 | 2-(Cyclopentylmethoxy)-5-methylaniline 95% | 2.5g | $1150 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0088753 | 2-(CYCLOPENTYLMETHOXY)-5-METHYLANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
| Matrix Scientific | 022096 | 2-(Cyclopentylmethoxy)-5-methylaniline | 500.00mg | $205 | 2026-05-18 | Buy |
| Matrix Scientific | 022096 | 2-(Cyclopentylmethoxy)-5-methylaniline | 500mg | $205 | 2021-12-16 | Buy |
Properties
Boiling point :334.8±22.0 °C(Predicted)
Density :1.043±0.06 g/cm3(Predicted)
pka :5.00±0.10(Predicted)
Density :1.043±0.06 g/cm3(Predicted)
pka :5.00±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|